 Recombinant human erythropoietin uremic bleeding Recombinant human erythropoietin hemostasis uremic patients anemia complete correction renal anemia risk hypertension encephalopathy thrombosis hyperkalemia aim minimum level packed cell volume PCV recombinant human erythropoietin prolonged bleeding time uremia patients chronic renal failure anemia prolonged bleeding time equal minutes specific treatment initial dose erythropoietin U/kg IV times week weeks dose U/kg normalization time Erythropoietin dose ranging U/kg/wk increase PCV range patients bleeding time patients significant negative correlation PCV bleeding time measurements Erythropoietin values red blood cell RBC distribution width basal weeks Platelet count platelet function parameters untreated patients changes parameters results controlled fashion erythropoietin shortens time uremic patients partial correction renal anemia enough bleeding time